Logo image of CCO

CLEAR CHANNEL OUTDOOR HOLDIN (CCO) Stock Fundamental Analysis

NYSE:CCO - New York Stock Exchange, Inc. - US18453H1068 - Common Stock - Currency: USD

1.11  -0.01 (-0.89%)

After market: 1.13 +0.02 (+1.8%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CCO. CCO was compared to 97 industry peers in the Media industry. CCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CCO had negative earnings in the past year.
CCO had a positive operating cash flow in the past year.
CCO had negative earnings in each of the past 5 years.
In multiple years CCO reported negative operating cash flow during the last 5 years.
CCO Yearly Net Income VS EBIT VS OCF VS FCFCCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

CCO has a worse Return On Assets (-4.49%) than 60.82% of its industry peers.
CCO has a better Return On Invested Capital (6.70%) than 72.16% of its industry peers.
CCO had an Average Return On Invested Capital over the past 3 years of 5.68%. This is in line with the industry average of 7.59%.
The 3 year average ROIC (5.68%) for CCO is below the current ROIC(6.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.49%
ROE N/A
ROIC 6.7%
ROA(3y)-4.07%
ROA(5y)-6.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.68%
ROIC(5y)N/A
CCO Yearly ROA, ROE, ROICCCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

Looking at the Operating Margin, with a value of 19.07%, CCO belongs to the top of the industry, outperforming 89.69% of the companies in the same industry.
In the last couple of years the Operating Margin of CCO has grown nicely.
Looking at the Gross Margin, with a value of 54.86%, CCO is in the better half of the industry, outperforming 68.04% of the companies in the same industry.
In the last couple of years the Gross Margin of CCO has grown nicely.
Industry RankSector Rank
OM 19.07%
PM (TTM) N/A
GM 54.86%
OM growth 3Y41.61%
OM growth 5Y14.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.5%
GM growth 5Y3.63%
CCO Yearly Profit, Operating, Gross MarginsCCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCO is destroying value.
CCO has more shares outstanding than it did 1 year ago.
CCO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCO has been reduced compared to a year ago.
CCO Yearly Shares OutstandingCCO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCO Yearly Total Debt VS Total AssetsCCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CCO has an Altman-Z score of -1.68. This is a bad value and indicates that CCO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CCO (-1.68) is worse than 78.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.68
ROIC/WACC0.96
WACC6.97%
CCO Yearly LT Debt VS Equity VS FCFCCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

CCO has a Current Ratio of 1.43. This is a normal value and indicates that CCO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.43, CCO perfoms like the industry average, outperforming 53.61% of the companies in the same industry.
CCO has a Quick Ratio of 1.43. This is a normal value and indicates that CCO is financially healthy and should not expect problems in meeting its short term obligations.
CCO has a Quick ratio of 1.43. This is comparable to the rest of the industry: CCO outperforms 54.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.43
CCO Yearly Current Assets VS Current LiabilitesCCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.50% over the past year.
The Revenue has been growing slightly by 4.95% in the past year.
The Revenue for CCO have been decreasing by -10.92% on average. This is quite bad
EPS 1Y (TTM)93.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%168.42%
Revenue 1Y (TTM)4.95%
Revenue growth 3Y-12.42%
Revenue growth 5Y-10.92%
Sales Q2Q%-30.63%

3.2 Future

Based on estimates for the next years, CCO will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.80% on average per year.
Based on estimates for the next years, CCO will show a decrease in Revenue. The Revenue will decrease by -7.62% on average per year.
EPS Next Y110.97%
EPS Next 2Y27.43%
EPS Next 3Y19.8%
EPS Next 5YN/A
Revenue Next Year-25.76%
Revenue Next 2Y-12.43%
Revenue Next 3Y-7.62%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CCO Yearly Revenue VS EstimatesCCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CCO Yearly EPS VS EstimatesCCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CCO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CCO Price Earnings VS Forward Price EarningsCCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

CCO's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.58
CCO Per share dataCCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

CCO's earnings are expected to grow with 19.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.43%
EPS Next 3Y19.8%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CCO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAR CHANNEL OUTDOOR HOLDIN

NYSE:CCO (7/28/2025, 8:13:38 PM)

After market: 1.13 +0.02 (+1.8%)

1.11

-0.01 (-0.89%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)08-05 2025-08-05
Inst Owners71.47%
Inst Owner Change-0.12%
Ins Owners15.6%
Ins Owner Change19.53%
Market Cap551.36M
Analysts50.77
Price Target1.54 (38.74%)
Short Float %5.91%
Short Ratio6.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-224.27%
Min EPS beat(2)-650.05%
Max EPS beat(2)201.51%
EPS beat(4)2
Avg EPS beat(4)-126.61%
Min EPS beat(4)-650.05%
Max EPS beat(4)201.51%
EPS beat(8)3
Avg EPS beat(8)-133.97%
EPS beat(12)4
Avg EPS beat(12)-86.37%
EPS beat(16)6
Avg EPS beat(16)-51.34%
Revenue beat(2)0
Avg Revenue beat(2)-15.29%
Min Revenue beat(2)-28.7%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-8.24%
Min Revenue beat(4)-28.7%
Max Revenue beat(4)-0.71%
Revenue beat(8)1
Avg Revenue beat(8)-5.54%
Revenue beat(12)1
Avg Revenue beat(12)-3.89%
Revenue beat(16)3
Avg Revenue beat(16)-2.81%
PT rev (1m)0%
PT rev (3m)-8.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.97%
EPS NY rev (1m)0%
EPS NY rev (3m)117.22%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF 4.26
P/B N/A
P/tB N/A
EV/EBITDA 10.58
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.26
OCFY23.49%
SpS3.03
BVpS-6.91
TBVpS-9.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.49%
ROE N/A
ROCE 8.48%
ROIC 6.7%
ROICexc 7.58%
ROICexgc 13.58%
OM 19.07%
PM (TTM) N/A
GM 54.86%
FCFM N/A
ROA(3y)-4.07%
ROA(5y)-6.1%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.68%
ROIC(5y)N/A
ROICexc(3y)6.02%
ROICexc(5y)N/A
ROICexgc(3y)10.41%
ROICexgc(5y)N/A
ROCE(3y)7.2%
ROCE(5y)N/A
ROICexcg growth 3Y24.11%
ROICexcg growth 5Y8.49%
ROICexc growth 3Y28.14%
ROICexc growth 5Y9.35%
OM growth 3Y41.61%
OM growth 5Y14.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.5%
GM growth 5Y3.63%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.27
Cap/Depr 69.96%
Cap/Sales 10.61%
Interest Coverage 0.72
Cash Conversion 25.13%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 1.43
Altman-Z -1.68
F-Score5
WACC6.97%
ROIC/WACC0.96
Cap/Depr(3y)74.61%
Cap/Depr(5y)62.93%
Cap/Sales(3y)11.21%
Cap/Sales(5y)9.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%168.42%
EPS Next Y110.97%
EPS Next 2Y27.43%
EPS Next 3Y19.8%
EPS Next 5YN/A
Revenue 1Y (TTM)4.95%
Revenue growth 3Y-12.42%
Revenue growth 5Y-10.92%
Sales Q2Q%-30.63%
Revenue Next Year-25.76%
Revenue Next 2Y-12.43%
Revenue Next 3Y-7.62%
Revenue Next 5YN/A
EBIT growth 1Y20.35%
EBIT growth 3Y24.01%
EBIT growth 5Y2.14%
EBIT Next Year73.92%
EBIT Next 3Y22.45%
EBIT Next 5YN/A
FCF growth 1Y79.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.66%
OCF growth 3YN/A
OCF growth 5Y-17.95%